Immunohistochemically (IHC), BC can be classified based on the expression of the oestrogen receptor (ER), the progesterone receptor (PR), and the receptor tyrosine-protein kinase erbB-2 (HER2) [2]. This evidence concerns the gene ESR1 and breast cancer.